MODERATOR
:
SPEAKER
(S):
Dennis Confer, MD, Chief Medical Officer, National Marrow Donor Program
State of the Sciencein Hematopoietic Cell Transplantation (HCT)
Dr. John Miller, MD, PhD, Vice President and Senior Medical Director, Donor Medical Services
Description
Unrelated HCT has steadily grown over the past 20 years. This session will provide a scientific update on what we have learned about donors and their recipients and how we apply this knowledge to donor and patient selection today. What are the donor related factors that impact patient outcome and how do they guide donor selection? How have the patient populations treated with transplantation changed over time and have we improved overall survival, and if so, how? What are the hot topics of research to continue to advance the state of the art of HSC as we move forward? Learn possible answers to these key unanswered questions in clinical transplantation that are the focus of current and planned research.
-
Describe other non-HLA donor and patient factors that influence the outcome of HCT
-
Learn what tools are available to assist you in choosing the best donor
-
Understand key unanswered questions in clinical transplantation that are the focus of current and planned research
-
Understand the most recent data on the impact of donor and recipient HLA matching on transplant outcome
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.